(CIDRAP News) To speed emergency responses to avian influenza and other animal and plant diseases, the United Nations Food and Agriculture Organization (FAO) inaugurated a new crisis management center (CMC) at its Rome headquarters today.
(CIDRAP News) Novartis, the Swiss-based drug manufacturer, today announced plans to build what it says will be the first US plant to make cell-culture-based influenza vaccines.
The facility will be built in Holly Springs, N.C., at a total cost of about $600 million, the company said in a news release. It will be able to produce about 50 million doses of seasonal trivalent (three-strain) flu vaccine annually.
(CIDRAP News) The US Department of Agriculture (USDA) and the United Nations Food and Agriculture Organization (FAO) announced today that a new animal disease crisis management center will begin operating in late July at FAO headquarters in Rome, with an initial focus on H5N1 avian influenza.
(CIDRAP News) An unusual strain of Escherichia coli O157 that standard laboratory culture methods cannot detect has been identified in a disease outbreak associated with a nursery in Scotland and in other cases in Scotland and England, according to recent news reports.
(CIDRAP news) – The European Commission (EC) reported yesterday that 741 cases of H5N1 avian influenza have been detected among about 60,000 wild birds tested in European Union states since February.
The EC presented its data during the United Nations Food and Agriculture Organization (FAO)/World Organization for Animal Health (OIE) International Scientific Conference on Avian Influenza and Wild Birds, which concluded yesterday in Rome.
(CIDRAP News) In an effort to modernize vaccine production while preparing for an influenza pandemic, the US government today awarded five contracts totaling more than $1 billion to develop cell-based technologies for making flu vaccines.
(CIDRAP News) European countries' plans for coping with an influenza pandemic are generally good but have a number of gaps, including a lack of detail on distribution of drugs and supplies, according to an analysis published last week by The Lancet.